24 February 2018
News and Views
Links and Services
fiogf49gjkf04Published ahead of print, the Alimentary Pharmacology & Therapeutics finds a reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients.
Anti-viral therapy in chronic hepatitis B is associated with a reduced risk of hepatoce
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors